Dedicated Outdoor Air System Market Is Driven by Commercial Category

The dedicated outdoor air system market was USD 3,849 million in 2022, and it is projected to reach USD 7,447 million by 2030, at a rate of 8.60% during the forecast period as per a report by P&S Intelligence. 

This growth of the industry is credited to the growing acceptance of these systems in commercial and residential applications, the growing attention to ideal environment, and the mounting HVAC equipment regulations by the government.

A dedicated outdoor air system is a part of the HVAC system and its main objective is to supply sufficient outdoor air. It also separates the exterior air from the interior air which regulates inside temperatures of the buildings. 

Numerous laws are implemented to control HVAC equipment and increase energy efficiency. The implementation of HVAC standards has resulted in the growth of dedicated outdoor air system market.  

The industry, based on capacity is categorized into greater than 60 tons, 40–60 tons, 20–40 tons, and less than 20 tons. The highest growth rate is projected in the 40–60 tons category, propelling at a rate of 9.1%, during the forecast period. With a multizone capacity and extra features, the 40–60 tons capacity offer 100% exterior air proficiency and energy efficiency.   

The industry, based on implementation is categorized into retrofit and new construction. Among these, the largest share of, more than 60% was held by the new construction category. This is credited to the growing investment in the commercial sector by major developing countries. 

On the other hand, the fastest growth is projected in the retrofit category. 

The industry is dominated by the commercial category. This is credited to the use of air-controlling systems to cool and heat indoor air in commercial areas. These systems improve the quality of air in commercial buildings. 

On the other hand, the highest growth rate of approximately 9%, is projected in the residential category. This can be credited to the rising disposable income around the world. 

North America held a significant share in 2022. This is because of the existence of various developed businesses, commercial spaces, and medical facilities, where the requirement for dedicated outdoor air systems is high; the massive demand from residential sectors; and the presence of key players, in the region.

Whereas, APAC will have the highest CAGR, of 9.5%, during the forecast period. This can be credited to the rising population, changing climatic conditions, growing construction activities, and friendly government policies. 

Furthermore, the needs for these systems are high in the commercial and residential sectors, with significant demand in Japan and China.   

Due to the rising awareness about the importance of indoor air quality, and the growing adoption of these devices from commercial and residential sectors, the industry will grow significantly in the coming years.


Share:

North America Is Dominating Recombinant Proteins Industry

In 2022, the recombinant proteins market was worth around USD 1,367.3 million, and it is projected to advance at an 11.2% CAGR from 2022 to 2030, hitting USD 3,203.7 million in 2030, according to P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3mjU09I

This development can be credited to the growing partnership between the pharmaceutical industry and universities and the increasing occurrence of primary communicable illnesses and hereditary disorders. Furthermore, the rising R&D on biological drugs and growing government expenditure for this purpose are projected to drive market growth.

The increasing occurrence of several rare syndromes, including neutropenia, multiple sclerosis, dwarfism, anemia, and cerebral apoplexy, is fuelling the demand for medications based on recombinant proteins.

Furthermore, such agents are utilized in the betterment of innovative treatments for serious chronic disorders, such as cardiovascular diseases, viral diseases, endocrine diseases, and cancer. The hike in the rate of these conditions is projected to boost the demand for recombinant protein drugs in the future as well.

The growth factors and chemokines category led the recombinant proteins market and is also projected to experience, approximately 12% CAGR, in the coming future. This can be ascribed to the utilization of growth factors and chemokines in numerous research on immunology, COVID-19, cancer, HIV/AIDS, and neurobiology.

In 2022, Biologics had the largest market share, approximately 60%, and is expected to grow at the highest pace in the coming few years. This is mainly because of the rising leaning of pharma firms and biopharma toward escalating their biosimilars and biologics research and development efforts and product pipelines, making innovative technologies, and enhancing the skill of bioprocessing.   

In 2022, North America led the market, generating a revenue share of approximately 45%, mainly because of the increasing occurrence of communicable and chronic syndromes and supportive government steps. Moreover, the increasing need for these items in the R&D studies conducted by the KEY players is driving the industry in the continent.

The APAC industry is projected to grow at the fastest pace in the coming few years. This can be ascribed to the widespread development in pharmaceutical contract development and production efforts in the past few years.

Furthermore, the increasing populace and its rising need for better accessibility to drugs; and the reduced cost of biopharmaceuticals, with the introduction of lucrative generics are leading to the development of the market in the region.

Additionally, rising GDP per capita, government-supportive healthcare steps, and rapid urbanization rate have extended the potential for the acceptance of recombinant proteins in the region.

Hence, the growing partnership between the pharmaceutical industry and universities and the increasing occurrence of primary communicable illnesses and hereditary disorders, are the major factors driving the recombinant proteins market.

Share:

Genome Editing Market Will Grow the Fastest in Asia-Pacific

As stated by a market research firm, P&S Intelligence, the total size of the genome editing market was USD 5,412.9 million in 2022, which will touch USD 20,397.8 million by 2030, powering at a rate of 18% in the years to come.

Get the sample pages of this report: https://bit.ly/3Kre5CW

There is a wide variety of features of genomics, for example agribusiness, drug research, forensics, veterinary sciences, and the identification of human genetic abnormalities, that are receiving strong focus from government as well as private biotech agencies. With NGS, the usage of genomics in forensics has significantly increased.

Furthermore, the usage of genome editing in marine engineering for the formation of nutraceuticals from algae is one of the developing trends. and Forensic sciences and personalized medicine are two other important areas where genomics is proving significant.

Based on application, the genome editing market is categorized into animal genetic engineering, cell line engineering and plant genetic engineering, amongst which the cell line engineering had the largest share, of about 50%, in 2022.

This growth has a lot to do with the growing use of cell line engineering in stem cell-based research. As a result of the rapid progressions, cell line engineering is extensively used for iPSCs, which help in changing the cell genetic content. The advent of cutting-edge gene editing methods, including CRISPR/Cas, ZFNs, and TALENs, has allowed profitable and suitable cell engineering.

Furthermore, the cell line development application is progressing because of the increasing requirement for the enhanced expression of therapeutic proteins, accompanied by its appropriateness for the anticipated post-translational alterations.

North America dominated the genome editing market, about 45%, in 2022. Furthermore, because of the expansion of gene therapy, increasing usage of genetically adapted crops, and easy obtainability of research funding, the region will contribute significantly to companies providing services and tools for gene editing.

Furthermore, the U.S. leads North America, chiefly because of the increasing private and government funding for genomics research.

Furthermore, the growing cases of rare disorders in Canada and the U.S. is pushing the market in North America.

The NIH say that about 25 to 30 million Americans suffered with over 7,000 rare ailments. This implies that 1 in 10 Americans suffer from rare ailments. Therefore, the growing requirement for emerging effective drugs drives the acceptance of novel DNA editing tools in these nations.

Also, the increasing count of research activities in genomics in Japan, India and China and the increasing investments made by private and public  organizations for gene editing purposes are the key factors pushing the market advance in the in the APAC.

Due to the increasing pace of tech advancements in genomics, it has powered the demand for genome editing all over the world.

Share:

The U.S. Is Dominating the North America Electric Scooters and Motorcycles Market

The North American electric scooters and motorcycles market was valued at USD 620 million in 2022, and this number is expected to reach USD 2,348 million by 2030, advancing at a CAGR of 18.10% during 2022–2030, according to P&S Intelligence.

This development can be ascribed to supportive government initiatives, from both federal and state levels. To encourage the acceptance of electric vehicles, the government is offering tax rebates and subsidies on the purchase of EVs. In addition, non-monetary subsidies, including licensing benefits, also the provision of separate lanes are boosting the acceptance of battery-operated two-wheelers in the continent.

In 2022, the U.S. had the larger share of 83%, based on value in North American electric scooters and motorcycles market, mainly because of the rapid acceptance of electric vehicle technologies in the nation. The country's government is helping in the purchasing of EVs by offering incentives and rebates, to decrease CO2 releases from gasoline-based vehicles. Furthermore, the new trend of using kick scooters for last-mile connectivity in numerous towns has contributed to market growth. 

The rising status of eco-friendly transportation systems, mainly to decrease the release of GHG, is the most vital reason behind the government initiatives to support EV sales. The help is offered through numerous subsidies and federal tax credits to consumers at the time of the purchase of EVs.

The electric scooters and motorcycles utilized for sharing services are set to experience the fastest growth by holding 82%, market share by the end of the decade. Two-wheeler sharing services are very comfortable for people, mainly everyday commuters, as they can adore riding to their destinations without bothering about owning and maintaining their vehicles.    

In 2022, the electric kick scooters category led the industry by selling maximum units with 63% market share, credited to their significant acceptance in sharing fleets. Producers have launched a large number of these scooters in the past few years as they are eco-friendly, easy to use, and economical. Moreover, they have lesser functioning costs than other automobiles, which indeed is contributing to their high acceptance in sharing fleets.


Share:

Cold Plasma Market Will Touch USD 5,568 Million by 2030

The total value of the global cold plasma market was USD,846 million in 2022, and it will rise at a growth rate of above 14.80% in the near future, to reach USD 5,568 million by 2030, according to P&S Intelligence. This can be credited to the profits of the cold plasma technology for a count of applications, including wound remedial, and the improvements in it.

In 2022, the polymer and plastic category held the largest market share, of above 32%. This can be credited to the fact that plastic and polymer applications need solid surface adherence to get the finest mechanical functionality and extended lifespan of plastic components.

Cold Plasma Market Size and Share Analysis Forecast, 2030

Observing the flared application of this technology in the polymer and plastic market, numerous key companies have started introducing systems and devices that permit this industry to utilize it.

Atmospheric cold plasma had the larger market share of the cold plasma market, credited to its utilization in numerous applications.

For example, it has shown promising outcomes in eczema treatment. Scientists from the Institute of Plasma Physics Chinese Academy of Sciences utilized an animal prototype to validate the possibilities of this technology in the cure of eczema with no side-effect. There is no treatment for atopic dermatitis, in simple words eczema, to date; it can be only managed with appropriate care.

In the coming few years, the wound healing category is projected to witness the highest revenue CAGR, of 15.4%. This is due to scientists having been utilizing cold plasma to accelerate the curing of exterior wounds for some time now. This method depends on making a high-voltage drop between a special device called the plasmodesma and the skin.

In 2022, North America dominated the market with the largest market share, 44%, it is projected to advance with a significant CAGR in the coming few years. This is mainly because of the surge in healthcare spending and Research and development activities.

For example, in March 2022, Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) issued a report on how a blend of the Canady Helios cold plasma and anti-BCL2A1 treatments might be helpful for patients suffering from breast cancer and other solid tumors.

Furthermore, the U.S. government has augmented its budget for cancer research. The Consolidated Appropriations Act, of 2023 has assigned USD 7.2 billion to the NCI, which was a USD 408 million rise over the FY 2022 funding, with USD 216 million for the characteristics of the Cancer Moonshot program being supervised by the NCI.

Hence, the profits of the cold plasma technology for a count of applications, including wound remedial, and the improvements in it, are the major factors driving the cold plasma market. 


Share:

Robotic Vision Market Will Reach USD 4,971 Million by 2030

The total value of the robotic vision market was USD 2,405 million in 2022, and it will rise at a growth rate of above 9.50% in the near future, to reach USD 4,971 million by 2030, according to P&S Intelligence.

This growth can be credited to the increasing need for quality inspection, the growing acceptance of cognitive humanoid robots, and the rising demand for quality items as well as protection in businesses.

Robotic Vision Market Size and Share Analysis Forecast, 2030

The 2D category is leading the market, this is mainly due to 2D vision systems being more dependable and simpler to run. Furthermore, these are less costly and are appropriate for several general applications, and are known to process pictures quicker.

While the 3D category is also rising at a noteworthy rate over the coming years. This can be mainly credited to its better manufacturing suppleness and high accuracy, and it allows the mechanization of everyday jobs and can-do complex tasks. It is also talented to distinguish between objects and observes human form.

In 2022, the hardware components held the largest market share, approximately 71%, and the same is projected to be dominant throughout the projection period. This dominance can be credited to the lucrative nature of hardware components including cameras, processors, frame grabbers, lighting, processors, and controllers.

Numerous applications require personalized cameras with several specifications like focal length and sensor size. Furthermore, the growing installation of machine systems and the rising acceptance of robots to mechanize monotonous processes are fuelling the development of the industry in this category.

On the basis of deployment, robotic guidance systems are dominating because of their varied utilization in collaborative robots and can lessen prices. Moreover, they can also surge the business process productivity. In the automotive market, these are effective and multipurpose, and they generally offer secondary feedback indications utilizing sensors to robots.

In 2022, North America held a major share of the robotic vision market at approximately 28%. This can be majorly credited to the quicker acceptance of new and progressive technologies and high per-capita income in the continent.

Along with these, the rising expenditure in the growth of these technologies by businesses and the growing deployment of robots across numerous industries are boosting the regional industry.

In industrial mechanization, these systems are utilized for the managing of numerous vital functions. Also, several manufacturers have started the employment of automation to automate procedures, which need repetitiveness.

Hence, the increasing need for quality inspection, the growing acceptance of cognitive humanoid robots, and the rising demand for quality items as well as protection in businesses are the major factors contributing to the growth of the robotic vision market.  


Share:

North America is Dominating Healthcare Facility Management Industry

The healthcare facility management market has garnered USD 88,114.0 million in 2021, and it is projected to rise at the rate of 8.3% from 2021 to 2030, to capture USD 180,397.0 million by 2030, As per the report by market research company, P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3nXW9ID

This growth can be ascribed to the snowballing investment in healthcare infrastructure growth, booming usage of modern technologies, rising patient numbers, increasing occurrence of chronic diseases and infections, and mounting healthcare costs.

The need for support services is escalating fast in the market, as hospitals and medical institutes are focusing on them in order to provide better-quality cures to patients. An integrated and engaged care service team might support healthcare amenities by removing the burden on healthcare specialists, thus letting patients recover faster, also encouraging a better environment, and improving the satisfaction of families, nurses, and patients.

The outsourcing category had the largest market share, of above 50%, in 2021. The outsourcing of in-house services is being majorly done because of the increasing healthcare expenses, difficulty of sophisticated ICD-10 medical coding systems, and placement of electronic health records.

The growing patient flow, and increasing requirement to check insurance entitlement and consult patient check-in records are making a solid burden on hospitals, which has forced them to outsource a few amenities, like facility management.

Soft services are projected to experience the fastest development in the coming few years, credited to a surge in the demand for waste disposal and recycling, security, outdoor area management, pest control, grounds maintenance, outdoor area management, and sanitization services which guarantees greater standards of safety, cleanliness, customer service, and hygiene. This encourages the best performance and quality of service, while also encouraging proactivity.

Fast technological enhancements are one of the top trends in the healthcare facilities management market. This is projected to offer several openings to healthcare providers in order to improve equipment uptime and working effectiveness. More than half the spending in the healthcare industry is credited to facility maintenance, therefore creating massive opportunities for service providers.

In 2021, the North American region dominated the industry, with a worth of USD 32,645.8 million, and also projected to be on the leading spot, till 2030, with a worth of USD 68,237.9 million in 2030 and a CAGR of 8.5%.

This majority can be credited to the strong healthcare infrastructure and the acceptance of several progressive technologies for healthcare facility management.

Hence, the snowballing investment in healthcare infrastructure growth, booming usage of modern technologies, rising patient number, increasing occurrence of chronic diseases and infections, and mounting healthcare costs are the major factors contributing to the growth of the healthcare facility management industry. 

Share:

Popular Posts